Dent-2 disease with a Bartter-like phenotype caused by the Asp631Glu mutation in the OCRL gene

Abstract Background Dent disease is an X-linked disorder characterized by low molecular weight proteinuria (LMWP), hypercalciuria, nephrolithiasis and chronic kidney disease (CKD). It is caused by mutations in the chloride voltage-gated channel 5 (CLCN5) gene (Dent disease-1), or in the OCRL gene (D...

Full description

Bibliographic Details
Main Authors: Eleni Drosataki, Sevasti Maragkou, Kleio Dermitzaki, Ioanna Stavrakaki, Dimitra Lygerou, Helen Latsoudis, Christos Pleros, Ioannis Petrakis, Ioannis Zaganas, Kostas Stylianou
Format: Article
Language:English
Published: BMC 2022-05-01
Series:BMC Nephrology
Subjects:
Online Access:https://doi.org/10.1186/s12882-022-02812-9
_version_ 1828202559607668736
author Eleni Drosataki
Sevasti Maragkou
Kleio Dermitzaki
Ioanna Stavrakaki
Dimitra Lygerou
Helen Latsoudis
Christos Pleros
Ioannis Petrakis
Ioannis Zaganas
Kostas Stylianou
author_facet Eleni Drosataki
Sevasti Maragkou
Kleio Dermitzaki
Ioanna Stavrakaki
Dimitra Lygerou
Helen Latsoudis
Christos Pleros
Ioannis Petrakis
Ioannis Zaganas
Kostas Stylianou
author_sort Eleni Drosataki
collection DOAJ
description Abstract Background Dent disease is an X-linked disorder characterized by low molecular weight proteinuria (LMWP), hypercalciuria, nephrolithiasis and chronic kidney disease (CKD). It is caused by mutations in the chloride voltage-gated channel 5 (CLCN5) gene (Dent disease-1), or in the OCRL gene (Dent disease-2). It is associated with chronic metabolic acidosis; however metabolic alkalosis has rarely been reported. Case presentation We present a family with Dent-2 disease and a Bartter-like phenotype. The main clinical problems observed in the proband included a) primary phosphaturia leading to osteomalacia and stunted growth; b) elevated serum calcitriol levels, leading to hypercalcemia, hypercalciuria, nephrolithiasis and nephrocalcinosis; c) severe salt wasting causing hypotension, hyperaldosteronism, hypokalemia and metabolic alkalosis; d) partial nephrogenic diabetes insipidus attributed to hypercalcemia, hypokalemia and nephrocalcinosis; e) albuminuria, LMWP. Phosphorous repletion resulted in abrupt cessation of hypercalciuria and significant improvement of hypophosphatemia, physical stamina and bone histology. Years later, he presented progressive CKD with nephrotic range proteinuria attributed to focal segmental glomerulosclerosis (FSGS). Targeted genetic analysis for several phosphaturic diseases was unsuccessful. Whole Exome Sequencing (WES) revealed a c.1893C > A variant (Asp631Glu) in the OCRL gene which was co-segregated with the disease in male family members. Conclusions We present the clinical characteristics of the Asp631Glu mutation in the OCRL gene, presenting as Dent-2 disease with Bartter-like features. Phosphorous repletion resulted in significant improvement of all clinical features except for progressive CKD. Angiotensin blockade improved proteinuria and stabilized kidney function for several years. Graphical abstract
first_indexed 2024-04-12T11:51:04Z
format Article
id doaj.art-f39bef399aa44cc9be56f260ffa08b2a
institution Directory Open Access Journal
issn 1471-2369
language English
last_indexed 2024-04-12T11:51:04Z
publishDate 2022-05-01
publisher BMC
record_format Article
series BMC Nephrology
spelling doaj.art-f39bef399aa44cc9be56f260ffa08b2a2022-12-22T03:34:11ZengBMCBMC Nephrology1471-23692022-05-012311710.1186/s12882-022-02812-9Dent-2 disease with a Bartter-like phenotype caused by the Asp631Glu mutation in the OCRL geneEleni Drosataki0Sevasti Maragkou1Kleio Dermitzaki2Ioanna Stavrakaki3Dimitra Lygerou4Helen Latsoudis5Christos Pleros6Ioannis Petrakis7Ioannis Zaganas8Kostas Stylianou9Nephrology Department, Heraklion University HospitalNephrology Department, Heraklion University HospitalNephrology Department, Heraklion University HospitalNephrology Department, Heraklion University HospitalNephrology Department, Heraklion University HospitalFoundation for Research and Technology – HellasNephrology Department, Heraklion University HospitalDepartment of Nephrology, Saarland University Medical CenterNeurogenetics Laboratory Medical School, University of CreteNephrology Department, Heraklion University HospitalAbstract Background Dent disease is an X-linked disorder characterized by low molecular weight proteinuria (LMWP), hypercalciuria, nephrolithiasis and chronic kidney disease (CKD). It is caused by mutations in the chloride voltage-gated channel 5 (CLCN5) gene (Dent disease-1), or in the OCRL gene (Dent disease-2). It is associated with chronic metabolic acidosis; however metabolic alkalosis has rarely been reported. Case presentation We present a family with Dent-2 disease and a Bartter-like phenotype. The main clinical problems observed in the proband included a) primary phosphaturia leading to osteomalacia and stunted growth; b) elevated serum calcitriol levels, leading to hypercalcemia, hypercalciuria, nephrolithiasis and nephrocalcinosis; c) severe salt wasting causing hypotension, hyperaldosteronism, hypokalemia and metabolic alkalosis; d) partial nephrogenic diabetes insipidus attributed to hypercalcemia, hypokalemia and nephrocalcinosis; e) albuminuria, LMWP. Phosphorous repletion resulted in abrupt cessation of hypercalciuria and significant improvement of hypophosphatemia, physical stamina and bone histology. Years later, he presented progressive CKD with nephrotic range proteinuria attributed to focal segmental glomerulosclerosis (FSGS). Targeted genetic analysis for several phosphaturic diseases was unsuccessful. Whole Exome Sequencing (WES) revealed a c.1893C > A variant (Asp631Glu) in the OCRL gene which was co-segregated with the disease in male family members. Conclusions We present the clinical characteristics of the Asp631Glu mutation in the OCRL gene, presenting as Dent-2 disease with Bartter-like features. Phosphorous repletion resulted in significant improvement of all clinical features except for progressive CKD. Angiotensin blockade improved proteinuria and stabilized kidney function for several years. Graphical abstracthttps://doi.org/10.1186/s12882-022-02812-9Dent diseaseBartter syndromeOCRLCase report
spellingShingle Eleni Drosataki
Sevasti Maragkou
Kleio Dermitzaki
Ioanna Stavrakaki
Dimitra Lygerou
Helen Latsoudis
Christos Pleros
Ioannis Petrakis
Ioannis Zaganas
Kostas Stylianou
Dent-2 disease with a Bartter-like phenotype caused by the Asp631Glu mutation in the OCRL gene
BMC Nephrology
Dent disease
Bartter syndrome
OCRL
Case report
title Dent-2 disease with a Bartter-like phenotype caused by the Asp631Glu mutation in the OCRL gene
title_full Dent-2 disease with a Bartter-like phenotype caused by the Asp631Glu mutation in the OCRL gene
title_fullStr Dent-2 disease with a Bartter-like phenotype caused by the Asp631Glu mutation in the OCRL gene
title_full_unstemmed Dent-2 disease with a Bartter-like phenotype caused by the Asp631Glu mutation in the OCRL gene
title_short Dent-2 disease with a Bartter-like phenotype caused by the Asp631Glu mutation in the OCRL gene
title_sort dent 2 disease with a bartter like phenotype caused by the asp631glu mutation in the ocrl gene
topic Dent disease
Bartter syndrome
OCRL
Case report
url https://doi.org/10.1186/s12882-022-02812-9
work_keys_str_mv AT elenidrosataki dent2diseasewithabartterlikephenotypecausedbytheasp631glumutationintheocrlgene
AT sevastimaragkou dent2diseasewithabartterlikephenotypecausedbytheasp631glumutationintheocrlgene
AT kleiodermitzaki dent2diseasewithabartterlikephenotypecausedbytheasp631glumutationintheocrlgene
AT ioannastavrakaki dent2diseasewithabartterlikephenotypecausedbytheasp631glumutationintheocrlgene
AT dimitralygerou dent2diseasewithabartterlikephenotypecausedbytheasp631glumutationintheocrlgene
AT helenlatsoudis dent2diseasewithabartterlikephenotypecausedbytheasp631glumutationintheocrlgene
AT christospleros dent2diseasewithabartterlikephenotypecausedbytheasp631glumutationintheocrlgene
AT ioannispetrakis dent2diseasewithabartterlikephenotypecausedbytheasp631glumutationintheocrlgene
AT ioanniszaganas dent2diseasewithabartterlikephenotypecausedbytheasp631glumutationintheocrlgene
AT kostasstylianou dent2diseasewithabartterlikephenotypecausedbytheasp631glumutationintheocrlgene